Biodistribution and Dosimetry of an Aqueous Solution Containing Sodium 3-( <sup>125</sup> I)iodo-4-hydroxybenzenesulfonate (IotrexTM) for Brachytherapy of Resected Malignant Brain Tumors

200012 citationsJournal Article

Authors

James B. Stubbs · Veloxiti (United States)

Alan D. Strickland

Abstract

Under routine clinical conditions, the radiation doses to normal organs are inconsequential. Should the maximum clinical load of Iotrex (16.7 GBq of 125I) be released intracerebrally, the radiation doses to all organs would be below the thresholds for deterministic effects.

Topics & Keywords

Advanced Radiotherapy Techniques Medical Imaging Techniques and Applications Glioma Diagnosis and Treatment

UN Sustainable Development Goals

Clean water and sanitation

Publication Details

Published in: Cancer Biotherapy and Radiopharmaceuticals

Volume 15, Issue 6, pp. 645-656

DOI: 10.1089/cbr.2000.15.645

Field-Weighted Citation Impact: 1.42